SI2861583T1 - Postopek za izdelavo hidroksiliranih ciklopentilpirimidinskih spojin - Google Patents

Postopek za izdelavo hidroksiliranih ciklopentilpirimidinskih spojin

Info

Publication number
SI2861583T1
SI2861583T1 SI201330302A SI201330302A SI2861583T1 SI 2861583 T1 SI2861583 T1 SI 2861583T1 SI 201330302 A SI201330302 A SI 201330302A SI 201330302 A SI201330302 A SI 201330302A SI 2861583 T1 SI2861583 T1 SI 2861583T1
Authority
SI
Slovenia
Prior art keywords
compounds
making
making hydroxylated
cyclopentylpyrimidine compounds
hydroxylated cyclopentylpyrimidine
Prior art date
Application number
SI201330302A
Other languages
English (en)
Slovenian (sl)
Inventor
Jonathan W. Lane
Travis Remarchuk
Sagar Shakya
Keith L. Spencer
Peter J. Stengel
Original Assignee
Array Biopharma, Inc.
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma, Inc., Genentech, Inc. filed Critical Array Biopharma, Inc.
Publication of SI2861583T1 publication Critical patent/SI2861583T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI201330302A 2012-05-17 2013-05-17 Postopek za izdelavo hidroksiliranih ciklopentilpirimidinskih spojin SI2861583T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261648421P 2012-05-17 2012-05-17
US201361785281P 2013-03-14 2013-03-14
PCT/US2013/041624 WO2013173736A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds
EP13725533.7A EP2861583B1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (1)

Publication Number Publication Date
SI2861583T1 true SI2861583T1 (sl) 2016-10-28

Family

ID=48534507

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330302A SI2861583T1 (sl) 2012-05-17 2013-05-17 Postopek za izdelavo hidroksiliranih ciklopentilpirimidinskih spojin

Country Status (18)

Country Link
US (1) US9309204B2 (enExample)
EP (1) EP2861583B1 (enExample)
JP (1) JP6214636B2 (enExample)
KR (1) KR20150020211A (enExample)
CN (1) CN104487430B (enExample)
AU (1) AU2013262568B2 (enExample)
BR (1) BR112014028570A2 (enExample)
CA (1) CA2873653A1 (enExample)
DK (1) DK2861583T3 (enExample)
ES (1) ES2588878T3 (enExample)
IL (1) IL235714A0 (enExample)
MA (1) MA37649B1 (enExample)
MX (1) MX2014013865A (enExample)
PL (1) PL2861583T3 (enExample)
RU (1) RU2014151017A (enExample)
SG (1) SG11201407613RA (enExample)
SI (1) SI2861583T1 (enExample)
WO (1) WO2013173736A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2861582T3 (en) 2012-05-17 2016-08-22 Array Biopharma Inc A process for preparing hydroxylated compounds cyclopentylpyrimidin
KR102074535B1 (ko) 2012-05-17 2020-02-06 제넨테크, 인크. 아미노산 화합물의 제조 방법
SG11201407618VA (en) 2012-05-17 2015-01-29 Genentech Inc Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof
EP2850200A1 (en) 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
CN105899492B (zh) 2013-11-15 2021-08-24 豪夫迈·罗氏有限公司 用于制备嘧啶基环戊烷化合物的方法
AU2014356984B2 (en) * 2013-11-27 2018-01-04 Sunshine Lake Pharma Co., Ltd. Processes for preparing dihydropyrimidine derivatives and intermediates thereof
CA2962901A1 (en) * 2014-09-26 2016-03-31 F.Hoffmann-La Roche Ag Processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
CN115916758A (zh) 2020-06-16 2023-04-04 豪夫迈·罗氏有限公司 用于制备羟基化环戊基嘧啶化合物的方法
KR102689151B1 (ko) * 2021-09-06 2024-07-29 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09506369A (ja) 1993-12-12 1997-06-24 アグロジーン・リミテッド 菌類感染から植物を保護するための新規方法
JP2001524079A (ja) 1997-04-07 2001-11-27 メルク エンド カンパニー インコーポレーテッド ガンの治療方法
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
AU3386600A (en) 1999-03-03 2000-09-21 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ES2239596T3 (es) * 1999-06-03 2005-10-01 Teikoku Hormone Mfg. Co., Ltd. Compuestos de pirazol sustituidos.
WO2001022963A1 (en) 1999-09-27 2001-04-05 Merck & Co., Inc. Method of preventing osteoporosis
JP4550811B2 (ja) 2003-06-09 2010-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング パピローマウイルスのインヒビター
AU2004293026B2 (en) 2003-11-21 2012-01-19 Array Biopharma Inc. AKT protein kinase inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法
KR20150091196A (ko) * 2007-07-05 2015-08-07 어레이 바이오파마 인크. Akt 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
EP2209775A1 (en) 2007-10-09 2010-07-28 UCB Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
CA2711699A1 (en) * 2008-01-09 2009-07-16 Array Biopharma Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
JP5551707B2 (ja) * 2008-10-15 2014-07-16 アムジエン・インコーポレーテツド スピロ環gpr40調節因子
JP5734956B2 (ja) 2009-04-15 2015-06-17 アッヴィ・インコーポレイテッド 抗ウィルス化合物
KR101398268B1 (ko) * 2009-10-23 2014-05-23 일라이 릴리 앤드 캄파니 Akt 억제제
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
KR102074535B1 (ko) 2012-05-17 2020-02-06 제넨테크, 인크. 아미노산 화합물의 제조 방법
EP2850200A1 (en) 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
DK2861582T3 (en) 2012-05-17 2016-08-22 Array Biopharma Inc A process for preparing hydroxylated compounds cyclopentylpyrimidin
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
CA2901577A1 (en) 2013-02-18 2014-08-21 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
US10131637B2 (en) 2013-03-15 2018-11-20 Shifa Biomedical Corporation Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Also Published As

Publication number Publication date
CN104487430A (zh) 2015-04-01
SG11201407613RA (en) 2015-01-29
JP2015518837A (ja) 2015-07-06
EP2861583A1 (en) 2015-04-22
BR112014028570A2 (pt) 2018-04-24
CN104487430B (zh) 2016-08-24
PL2861583T3 (pl) 2016-12-30
WO2013173736A1 (en) 2013-11-21
ES2588878T3 (es) 2016-11-07
US20150099881A1 (en) 2015-04-09
IL235714A0 (en) 2015-02-01
RU2014151017A (ru) 2016-07-10
MA37649A1 (fr) 2016-06-30
HK1208673A1 (en) 2016-03-11
AU2013262568A1 (en) 2015-01-22
MX2014013865A (es) 2015-05-07
CA2873653A1 (en) 2013-11-21
EP2861583B1 (en) 2016-06-29
US9309204B2 (en) 2016-04-12
DK2861583T3 (en) 2016-10-03
MA37649B1 (fr) 2017-03-31
KR20150020211A (ko) 2015-02-25
AU2013262568B2 (en) 2017-08-31
JP6214636B2 (ja) 2017-10-18

Similar Documents

Publication Publication Date Title
ZA201500664B (en) Process for making isoquinoline compounds
EP2867189A4 (en) PROCESS FOR PRODUCING ACRYLATE
PT2875062T (pt) Processo de síntese de poliarilétercetonas
GB201103499D0 (en) Process
GB201107072D0 (en) Process
SG11201405572QA (en) Process for producing polydienes
ZA201409261B (en) Process for making hydroxylated cyclopentylpyrimidine compounds
IL235714A0 (en) A process for preparing hydroxylated cyclopentylpyrimidine compounds
IL227872A0 (en) A process for the preparation of n-converted phenylhydroxylamines
EP2714701A4 (en) PROCESS FOR FOSAPREPITANT
ZA201308852B (en) Process of making beta-hydroxyamino compounds
GB201101370D0 (en) Process
TWI562980B (en) Process for producing phenol
EP2806042A4 (en) METHOD FOR PRODUCING A TAPERIC PLATE
IL236159A0 (en) Process for the production of methylbutanol
GB2488894B (en) Process for producing V-Coelenterazine compounds
GB201107073D0 (en) Process
SG11201503421WA (en) Process for producing phenol
TWI562986B (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
SG11201501831WA (en) Aminoethylation process for producing aryloxyalkylene amine compounds
SG11201500058VA (en) Process for producing phenol
PL2850051T3 (pl) Sposób wytwarzania kumenu
SG11201501567QA (en) Method for producing 7-octenal
IL233433A (en) A process for making affluent
SG11201401492RA (en) Process for making esters